Enveric Biosciences, Inc. 8-K

What Happened Enveric Biosciences, Inc. filed a Current Report on Form 8-K (Item 7.01) on June 9, 2026 to disclose that management prepared an investor presentation to be released on or about June 8, 2026. The presentation is furnished as Exhibit 99.1 to the filing and will be available on the company’s investor events webpage; the company said it may use the presentation, possibly with modifications, in future investor, analyst and partner presentations.

Key Details

• Filing date: Form 8-K filed June 9, 2026 (Regulation FD disclosure, Item 7.01).
• Presentation release: Investor Presentation to be posted on or about June 8, 2026 and furnished as Exhibit 99.1.
• Access: Presentation available via https://www.enveric.com/investors/events/.
• Legal note: Materials on the website are not incorporated by reference and the furnished presentation is not deemed “filed” for purposes of Section 18 of the Exchange Act (General Instruction B.2).

Why It Matters This filing signals that Enveric has provided an updated investor slide deck and corporate messaging to the market under Reg FD. While the 8‑K does not report earnings or other financial results, the presentation may contain current strategy, pipeline, or corporate updates useful to shareholders, analysts, and potential partners. Investors should review the posted Exhibit 99.1 on the company’s website for details, keeping in mind the company treated the deck as furnished (not filed) under SEC rules.